Cellmig Biolabs

ICON is a leading Contract Research Organization (CRO) that provides a comprehensive array of clinical consulting and commercial services across various sectors, including biotech, pharmaceuticals, and medical devices. With an extensive portfolio in therapeutics,ICON specializes in transformative therapies, possessing deep therapeutic expertise and focusing on patient-centric solutions. At the forefront of precision medicine, ICON's Specialty Laboratories support drug and diagnostic co-development through rigorous assay design and validation. Their advanced technologies and dedicated scientific teams ensure reliable and accurate results that drive pivotal clinical endpoints, reinforcing their commitment to enhancing research and development outcomes in the healthcare sector. Generated from the website

Sanofi Genzyme is a global biopharmaceutical company committed to improving access to healthcare through innovative solutions in various therapeutic areas such as immunology, neurology, oncology, and rare diseases. The company emphasizes sustainable practices and the importance of diversity, equity, and inclusion within its operations and workforce. With a robust research and development pipeline, Sanofi Genzyme leverages advanced technologies, including artificial intelligence, to enhance its drug manufacturing processes and clinical trials. The company actively engages in external scientific collaboration and partnerships to foster innovation and address global healthcare challenges. Generated from the website

Quiver Bioscience, formerly known as Q-State Biosciences, is a leading biotechnology company based in Cambridge, MA, dedicated to revolutionizing drug development for neurological diseases. With a decade of scientific advancements and cutting-edge technology, Quiver utilizes human disease models, artificial intelligence, and a state-of-the-art platform to discover and develop transformative medicines for patients living with brain disorders. Driven by their innovative approach, Quiver integrates scalable biology, advanced engineering, and surrogate models to identify novel therapeutic targets and candidate molecules. Their proprietary cellular models capture the complexities of human biology, while their lineup of technologies and instrumentation measures hundreds of properties associated with cellular function per neuron. Through their analytics algorithms, Quiver extracts data from individual cells to gain insights into disease states and optimize therapeutic candidates with greater translational potential.Generated from the website